Advanced Practice: Anti-NMDA Receptor Encephalitis
Tue, 02/06/2018 - 5:00am
Editor:
Pathogenesis → antibodies against NMDA receptor
Epidemiology → Early 20s or pediatrics; female predominance
Clinical → often present with bizarre behavior or AMS or “weird movements”
- About 60% have to have cancer → paraneoplastic → ovarian teratoma most common
- Initial flu like prodrome that progress overs 1-2 weeks to psychosis, AMS, dyskinesias/
choreiform, seizures - Increased muscle tone, memory problem
- New psych symptoms → hallucinations, paranoia, agitation
- Autonomic instability → tachycardia, hypertension, hypoventilation
Differential Diagnosis → When considering Meningitis/ Encephalitis v. Brain mass v. Endocrine emergency v.
Serotonin Syndrome/ Neuroleptic Malignant Syndrome v. Ketamine/ PCP intoxication - consider
NMDA receptor
Diagnosis → CSF (100% sensitive) and serum (85% sensitive); send for a NMDA-R antibody
- MRI abnormal in 40% of cases but very non-specific; EEG non-specific
Management = supportive care + high dose steroids/ GC/ IVIG/ plasma exchange - Pelvic US needed as inpatient, along with cancer work up
- Prognosis → 75% cured with zero to mild deficits; 7% mortality
References
- Lawrence JE, Fountain DM, Agius M. Anti-NMDA Encephalitis in the Acute Setting. Psychiatr Danub. 2014;26 Suppl 1:269-272